Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Effectiveness of Localized Lockdowns in the COVID-19 Pandemic

View ORCID ProfileYige Li, View ORCID ProfileEduardo A. Undurraga, View ORCID ProfileJosé R. Zubizarreta
doi: https://doi.org/10.1101/2020.08.25.20182071
Yige Li
1Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Office 307-Z, Boston, MA 02115
2Department of Biostatistics, Harvard School of Public Health, Huntington Avenue, Boston, MA 02115, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yige Li
Eduardo A. Undurraga
3Escuela de Gobierno, Pontificia Universidad Católica de Chile, Vicuña Mackenna 4860, Macul, Santiago 7820436, Chile
4Millennium Initiative for Collaborative Research in Bacterial Resistance (MICROB-R), Chile
5Research Center for Integrated Disaster Risk Management (CIGIDEN), Santiago, Region Metropolitana, Chile
6CIFAR Azrieli Global Scholars program, CIFAR, Toronto, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eduardo A. Undurraga
José R. Zubizarreta
1Department of Health Care Policy, Harvard Medical School, 180A Longwood Avenue, Office 307-Z, Boston, MA 02115
2Department of Biostatistics, Harvard School of Public Health, Huntington Avenue, Boston, MA 02115, USA
7Department of Statistics, Harvard Faculty of Arts and Sciences, 1 Oxford Street, Cambridge, MA 02138, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for José R. Zubizarreta
  • For correspondence: zubizarreta@hcp.med.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Non-pharmaceutical interventions, such as social distancing and lockdowns, have been essential to control the COVID-19 pandemic. In particular, localized lockdowns in small geographic areas have become an important policy intervention to prevent viral spread in cases of resurgence. These localized lockdowns can result in lower social and economic costs compared to larger-scale suppression strategies. Using an integrated dataset from Chile (March 3 through June 15, 2020) and a novel synthetic control approach, in this paper we estimate the effect of localized lockdowns, disentangling its direct and indirect causal effects on SARS-CoV-2 transmission. Our results show that the effects of localized lockdowns are strongly modulated by their duration and are influenced by indirect effects from neighboring geographic areas. Our estimates suggest that extending localized lockdowns can slow down the pandemic; however, localized lockdowns on their own are insufficient to control pandemic growth in the presence of indirect effects from contiguous neighboring areas that do not have lockdowns. These results provide critical empirical evidence about the effectiveness of localized lockdowns in interconnected geographic areas.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was partially supported by a grant from the Alfred P. Sloan Foundation (G-2018-10118), an award from the Patient-Centered Outcomes Research Institute (PCORI; ME-2019C1-16172), and the ANID Millennium Science Initiative/ Millennium Initiative for Collaborative Research on Bacterial Resistance, MICROB-R NCN17_081, and ANID/FONDAP CIGIDEN 15110017. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Our research uses only publicly available data collected by the Chilean government; subjects cannot be identified directly or through identifiers. It is considered exempt by the Comite Etico Cientifico of Pontificia Universidad Catolica de Chile.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • email: yige_li{at}hcp.med.harvard.edu.

  • email: eundurra{at}uc.cl.

  • email: zubizarreta{at}hcp.med.harvard.edu.

  • We had an English native speaker check the writing. We made minor changes in the introduction and discussion for added clarity. Last, we updated the organization of figures (separated panels, legend in a separate box, no titles within the figures) and the figure legends for clarity.

Data Availability

Datasets used and/or analyzed during the current study are available from Base de Datos CoVID-19 repository, Ministerio de Ciencia, Tecnologia, Conocimiento, e Innovacion.

http://www.minciencia.gob.cl/covid19

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted November 17, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Effectiveness of Localized Lockdowns in the COVID-19 Pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Effectiveness of Localized Lockdowns in the COVID-19 Pandemic
Yige Li, Eduardo A. Undurraga, José R. Zubizarreta
medRxiv 2020.08.25.20182071; doi: https://doi.org/10.1101/2020.08.25.20182071
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Effectiveness of Localized Lockdowns in the COVID-19 Pandemic
Yige Li, Eduardo A. Undurraga, José R. Zubizarreta
medRxiv 2020.08.25.20182071; doi: https://doi.org/10.1101/2020.08.25.20182071

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (161)
  • Allergy and Immunology (414)
  • Anesthesia (90)
  • Cardiovascular Medicine (857)
  • Dentistry and Oral Medicine (159)
  • Dermatology (97)
  • Emergency Medicine (248)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (393)
  • Epidemiology (8556)
  • Forensic Medicine (4)
  • Gastroenterology (383)
  • Genetic and Genomic Medicine (1747)
  • Geriatric Medicine (167)
  • Health Economics (372)
  • Health Informatics (1239)
  • Health Policy (620)
  • Health Systems and Quality Improvement (467)
  • Hematology (196)
  • HIV/AIDS (372)
  • Infectious Diseases (except HIV/AIDS) (10290)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (211)
  • Neurology (1676)
  • Nursing (97)
  • Nutrition (248)
  • Obstetrics and Gynecology (326)
  • Occupational and Environmental Health (450)
  • Oncology (928)
  • Ophthalmology (263)
  • Orthopedics (101)
  • Otolaryngology (172)
  • Pain Medicine (112)
  • Palliative Medicine (40)
  • Pathology (252)
  • Pediatrics (534)
  • Pharmacology and Therapeutics (248)
  • Primary Care Research (207)
  • Psychiatry and Clinical Psychology (1765)
  • Public and Global Health (3834)
  • Radiology and Imaging (623)
  • Rehabilitation Medicine and Physical Therapy (319)
  • Respiratory Medicine (520)
  • Rheumatology (208)
  • Sexual and Reproductive Health (165)
  • Sports Medicine (158)
  • Surgery (190)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)